Trimeris Shareholder Tries To Halt $81M Arigene Deal

Law360, New York (October 22, 2009, 12:11 PM EDT) -- Aiming to put the brakes on Arigene Co. Ltd.'s acquisition of biopharmaceutical company Trimeris Inc., a Trimeris shareholder has launched a putative class action alleging that the company and its board of directors are withholding material information about the deal.

In the lawsuit filed Wednesday in the U.S. District Court for the Middle District of North Carolina, shareholder Robert Haas asked a judge to enjoin the deal and require Trimeris and its board to disseminate an “accurate and complete” recommendation statement that fully informs shareholders about...
To view the full article, register now.